Cargando…

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH

BACKGROUND: Compounds in clinical development for nonalcoholic steatohepatitis (NASH) improve liver histopathology in diet-induced obese mouse models of biopsy-confirmed NASH. Since the biopsy section used for histopathological evaluation represents only < 1% of the whole mouse liver, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baandrup Kristiansen, Maria Nicoline, Veidal, Sanne Skovgård, Christoffersen, Christina, Feigh, Michael, Vrang, Niels, Roth, Jonathan David, Erickson, Mary, Adorini, Luciano, Jelsing, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935483/ https://www.ncbi.nlm.nih.gov/pubmed/31883514 http://dx.doi.org/10.1186/s12876-019-1149-z

Ejemplares similares

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
por: Roth, Jonathan D., et al.
Publicado: (2019)

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH
por: Møllerhøj, Mathias B., et al.
Publicado: (2022)

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
por: Roth, Jonathan D, et al.
Publicado: (2018)

Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
por: Boland, Michelle L, et al.
Publicado: (2019)

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
por: Ægidius, Helene M., et al.
Publicado: (2020)

Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis
por: Tølbøl, Kirstine S., et al.
Publicado: (2018)

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
por: Hansen, Henrik H., et al.
Publicado: (2020)

The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
por: Perakakis, Nikolaos, et al.
Publicado: (2020)

NASH-inducing Diets in Göttingen Minipigs
por: Pedersen, Henrik D., et al.
Publicado: (2020)

Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model
por: Anfuso, Beatrice, et al.
Publicado: (2020)

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents
por: Dalbøge, Louise S., et al.
Publicado: (2015)

An optimized protocol for isolation of hepatic leukocytes retrieved from murine and NASH liver biopsies
por: Bahrami, Ehsan, et al.
Publicado: (2023)

Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
por: Heinemann, Fabian, et al.
Publicado: (2022)

The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice
por: Cucak, Helena, et al.
Publicado: (2016)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study
por: Amir, E, et al.
Publicado: (2009)

Biopsy Ratio of Suspected to Confirmed Sarcoma Diagnosis
por: Mosku, Nasian, et al.
Publicado: (2022)

An Online Mammography Database with Biopsy Confirmed Types
por: Cai, Hongmin, et al.
Publicado: (2023)

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
por: Hansen, Henrik H., et al.
Publicado: (2021)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Trichostasis Spinulosa Confirmed by Standard Skin Surface Biopsy
por: Gündüz, Özge, et al.
Publicado: (2012)

Frequency of Gingival Pregnancy Tumor in Iran (Confirmed by Biopsy)
por: Nejad, Elaheh Sadat Tabatabaei, et al.
Publicado: (2014)

Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease
por: Wang, Yiting, et al.
Publicado: (2021)

Biopsy Confirmed Subacute Thyroiditis Associated With COVID-19
por: Maldonado, Francisco Javier López, et al.
Publicado: (2021)

Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD Patients
por: Kamada, Yoshihiro, et al.
Publicado: (2022)

Biopsy Confirmed Doxycycline Induced Gastric Mucosal Injury
por: Gaulden, Hannah, et al.
Publicado: (2022)

Serum Markers of Liver Fibrosis: Combining the BIPED Classification and the Neo-Epitope Approach in the Development of New Biomarkers
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II
por: Roostalu, Urmas, et al.
Publicado: (2020)

Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass
por: Barkholt, Pernille, et al.
Publicado: (2016)

Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis.
por: Boland, Michelle L., et al.
Publicado: (2020)

NEPHROGENIC SYSTEMIC FIBROSIS: REVIEW OF 408 BIOPSY-CONFIRMED CASES
por: Zou, Zhitong, et al.
Publicado: (2011)

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

Definitive Confirmation of Erythropoietic Protoporphyria via Re-biopsy Three Years After Initial Liver Biopsy at Age 15
por: Miyakami, Yuko, et al.
Publicado: (2023)

Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats
por: Hansen, Carl Frederik, et al.
Publicado: (2013)

Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort
por: Troelstra, Marian A., et al.
Publicado: (2021)

Idiopathic Isolated Omental Panniculitis Confirmed by Percutaneous CT-Guided Biopsy
por: Jeon, Eun Jung, et al.
Publicado: (2009)

Hypersensitivity myocarditis confirmed by cardiac magnetic resonance imaging and endomyocardial biopsy
por: Park, Yumi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uim0japt9ktma8tr074o7n0qr8